Clear cell carcinoma of the ovary: a clinicopathologic analysis of 34 cases

1991 ◽  
Vol 1 (3) ◽  
pp. 113-119 ◽  
Author(s):  
M. Imachi ◽  
N. Tsukamoto ◽  
T. Shimamoto ◽  
T. Hirakawa ◽  
K. Uehira ◽  
...  

The clinical and pathologic aspects of 34 cases of pure clear cell carcinoma of the ovary are discussed. These tumors represented 12.1% (34/280) of all ovarian cancers. The ages of the patients ranged from 34 to 78 years (mean 51.6 years) and 59% were postmenopausal. The clinical stages (FIGO) of these patients were as follows; I 22, II 5, III 6, and IV 1. Thirty-nine percent of the patients were nulligravidas. The diameters of the tumor varied from 6 to 31 cm (mean 16 cm), and 47% of the patients had endometriosis. Thirteen tumors were directly connected with endometriosis and this suggests that some ovarian clear cell carcinoma arose from the epithelium of an endometriotic cyst. Three architectural patterns (solid, papillary, and tubulocystic) were recognized. Forty-seven percent of the tumors were predominantly papillary and 24% contained mixtures of these three patterns. Four cell types such as clear, hobnail, eosinophilic, and flattened were also seen. Thirty-eight percent of the tumors had psammoma bodies. Histological patterns and cell types were not prognostic factors, and the stage at presentation was the most important prognostic factor. The 5-year survival rate was 54% (7/13) which was better than that in patients with serous adenocarcinoma of the ovary. The estimated survivals in patients with clear cell carcinoma however, were worse than those in patients with serous adenocarcinoma when compared stage for stage.

2007 ◽  
Vol 17 (2) ◽  
pp. 426-432 ◽  
Author(s):  
T. Nakazato ◽  
T. Kanuma ◽  
T. Tamura ◽  
L. S. Faried ◽  
H. Aoki ◽  
...  

Clear cell adenocarcinoma of the ovary has a poor prognosis due to chemoresistance and early metastasis to the lymph nodes. It also can result in endometriosis and is the second most frequent type of ovarian cancer in Japan. Serous adenocarcinoma of the ovary is another common epithelial cancer tissue subtype in Japan, and it is highly sensitive to chemotherapy. In the current study, we examined the differential expression of genes in these types of ovarian cancer and tried to analyze their functions, especially as they relate to chemoresistance. We used differential display to compare clear cell carcinoma and serous adenocarcinoma of the ovary. We identified sperm protein 17 (SP17) as a candidate gene related to the chemoresistance of clear cell carcinoma. Its differential expression was confirmed by real-time polymerase chain reaction. Because the function of the SP17 gene in ovarian cancer is not known, we examined the effect of small interfering RNA targeting the SP17 gene on the chemoresistance and proliferation of ES-2 ovarian cancer cells to paclitaxel, currently the most effective treatment for ovarian cancer. We found that this treatment decreased the chemoresistance of these cells to paclitaxel. Our results strongly suggest that SP17 plays a role in the resistance of clear cell carcinoma to chemotherapy without influencing their ability to proliferate


Author(s):  
Angiolo Gadducci ◽  
Francesco Multinu ◽  
Stefania Cosio ◽  
Silvestro Carinelli ◽  
Mariacristina Ghioni ◽  
...  

2016 ◽  
Vol 16 ◽  
pp. 1-4
Author(s):  
Zhen Ni Zhou ◽  
Christina Tierney ◽  
William H. Rodgers ◽  
Long Nguyen ◽  
David Fishman

2012 ◽  
Vol 126 (3) ◽  
pp. 481-490 ◽  
Author(s):  
Marcela G. del Carmen ◽  
Michael Birrer ◽  
John O. Schorge

Sign in / Sign up

Export Citation Format

Share Document